Two injections of erythropoietin correct moderate anemia in most patients awaiting orthopedic surgery

Canadian Journal of Anesthesia

Volumn 52, Issue 2, 2005, Pages 160-165

  Rosencher, Nadia ^a   Poisson, Dominique ^b   Albi, Aline ^a   Aperce, Martine ^c   Barré, Jeanne ^d   Samama, Charles Marc ^e  

^a Cochin Hospital ^*  (France)

^b BICHAT HOSPITAL   (France)

^c Poitiers University Hospital   (France)

^d University hospital of Reims   (France)

^e AVICENNE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IRON; RECOMBINANT ERYTHROPOIETIN;

AGED; ANEMIA; ARTICLE; BLOOD AUTOTRANSFUSION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; ELECTIVE SURGERY; ENERGY; ERYTHROPOIESIS; FEMALE; HEMATOCRIT; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORTHOPEDIC SURGERY; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL ANALYSIS;

EID: 16344366880     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03027722     Document Type: Article

References (26)

1. Etchason J, Petz L, Keeler E, et al. The cost effectiveness of preoperative autologous blood donations. N Engl J Med 1995; 332: 719-24.
2. Birkmeyer JD, Goodnough LT, AuBuchon JP, Noordsij PG, Littenberg B. The cost-effectiveness of preoperative autologous blood donation for total hip and knee replacement. Transfusion 1993; 33: 544-51.
3. Borghi B, Casati A. Incidence and risk factors for allogenic blood transfusion during major joint replacement using an integrated autotransfusion regimen. The Rizzoli Study Group on Orthopaedic Anaesthesia. Eur J Anaesthesiol 2000; 17: 411-7.
4. Innerhofer P, Walleczek C, Luz G, et al. Transfusion of buffy coat-depleted blood components and risk of postoperative infection in orthopedic patients. Transfusion 1999; 39: 625-32.
5. Bierbaum BE, Callaghan JJ, Galante JO, Rubash HE, Tooms RE, Welch RB. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone Joint Surg Am 1999; 81: 2-10.
6. Rosencher N, Kerkkamp HE, Macheras G, et al. Orthopedic surgery transfusion hemoglobin European overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003; 43: 459-69.
7. Murphy P, Heal JM, Blumberg N. Infection or suspected infection after hip replacement surgery with autologous or homologous blood transfusions. Transfusion 1991; 31: 212-7.
8. Houston F, Foster JD, Chong A, Hunter N, Bostock CJ. Transmission of BSE by blood transfusion in sheep. Lancet 2000; 356: 999-1000.
9. Mercuriali F, Inghilleri G. Proposal of an algorithm to help the choice of the best transfusion strategy. Curr Med Res Opin 1996; 13: 465-78.
10. Brecher ME, Rosenfeld M. Mathematical and computer modeling of acute normovolemic hemodilution. Transfusion 1994; 34: 176-9.
11. Société Française d'anesthésie et de réanimation. Utilisation des globules rouges pour la compensation des pertes sanguines en chirurgie de l'adulte. Conférence de consensus. Ann Fr Anesth Réanim 1995; 14(Suppl 1): 1-117.
12. American College of Physicians. Practice strategies for elective red blood cell transfusion. Ann Intern Med 1992; 116: 403-6.
13. Priestman TJ, Baum M. Evaluation of quality of life in patients receiving treatment for advanced breast cancer. Lancet 1976; 24: 899-901.
14. Laupacis A, Fergusson D. Erythropoietin to minimize perioperative blood transfusion: a systematic review of randomized trials. The International Study of Perioperative Transfusion (ISPOT) Investigators. Transfus Med 1998; 8: 309-17.
15. Goodnough LT, Monk TG, Andriole GL. Erythropoietin therapy. N Engl J Med 1997; 336: 933-8.
16. Small M, Lowe GD, Cameron E, Forbes CD. Contribution of the haematocrit to the bleeding time. Haemostasis 1983; 13: 379-84.
17. Mercuriali F. Epoetin alfa increases the volume of autologous blood donated by patients scheduled to undergo orthopedic surgery. Semin Hematol 1996; 33(Suppl 2): 10-2.
18. Goodnough LT. Autologous blood donation. Crit Care 2004; 8(Suppl 2): S49-52.
19. Goodnough LT. Risks of blood transfusion. Crit Care Med 2003; 31(Suppl): S678-86.
20. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Transfusion medicine. Second of two parts. Blood conservation. N Engl J Med 1999; 340: 525-33.
21. Weiskopf RB, Feiner J, Hopf HW, et al. Oxygen reverses deficits of cognitive function and memory and increased heart rate induced by acute severe isovolemic anemia. Anesthesiology 2002; 96: 871-7.
22. Watanabe A, Kato N, Kato T. Effects of creatine on mental fatigue and cerebral hemoglobin oxygenation. Neurosci Res 2002; 42: 279-85.
23. Sobrero A, Puglisi F, Guglielmi A, et al. Fatigue: a main component of anemia symptomatology. Semin Oncol 2001; 28(Suppl 8): 15-8.
24. Gabrilove JL, Cleeland CS, Livingston RB, Sarokhan B, Winer E, Einhorn LH. Clinical evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: improvements in hemoglobin and quality of life are similar to three-times-weekly dosing. J Clin Oncol 2001; 19: 2875-82.
25. Littlewood TJ, Bajetta E, Nortier JW, Vercammen E, Rapoport B; Epoetin Alfa Study Group. Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial. J Clin Oncol 2001; 19: 2865-74.
26. Keating EM, Ranawat CS, Cats-Baril W. Assessment of postoperative vigor in patients undergoing elective total joint arthroplasty: a concise patient- and caregiver-based instrument. Orthopedics 1999; 22(1 Suppl): s119-s28.